PXMD

PaxMedica, Inc.

0.66 USD
+0.44 (+198.01%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

PaxMedica, Inc. stock is up 135.75% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 1 June’s closed higher than May.

About PaxMedica, Inc.

PaxMedica is an early clinical stage biopharmaceutical company focusing on the development of anti-purinergic therapies (or APT), for the treatment of neurodevelopmental disorders, including autism spectrum disorder (or ASD), and Fragile X tremor-ataxia syndrome (or FXTAS).